BPC-157 Spray is a research-use peptide preparation containing BPC-157, a synthetic pentadecapeptide that has been investigated extensively in preclinical research. Scientific literature has examined BPC-157 across areas including peptide biology, gastrointestinal research models, vascular signaling, tissue biology, and molecular pathways. Helix Bio supplies BPC-157 Spray for laboratory and scientific research only. It is not intended for human or veterinary administration, self-experimentation, diagnosis, treatment, or prevention of disease. Researchers evaluating BPC-157 should consider the compound's experimental status, the limitations of existing clinical evidence, and the exact specifications and analytical documentation associated with the product lot.
HPLC certified
Independent analysis
Highest standard
Full traceability
BPC-157, commonly referred to as Body Protection Compound 157, is a synthetic pentadecapeptide consisting of 15 amino acids. The sequence commonly reported in scientific literature is:
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
BPC-157 has been studied extensively in animal and laboratory models. Research has examined biological activity involving gastrointestinal, vascular, inflammatory, neurological, and tissue-related experimental endpoints. Much of the literature remains preclinical, and the findings should not be treated as evidence that BPC-157 is an established human therapy.
BPC-157 Spray provides a spray-format presentation of BPC-157 for research environments in which a spray formulation is relevant to the experimental design.
The formulation and concentration of a spray product should not be inferred from the compound name alone. Researchers should verify the current product specification, lot information, concentration, formulation, storage requirements, and Certificate of Analysis before incorporating a product into a laboratory protocol.
This distinction is particularly important for BPC-157 because recent scientific literature has highlighted unresolved formulation, pharmacokinetic, characterization, and translational-development questions. A 2026 review concluded that pharmaceutical development remains limited and that standardized formulations and validated pharmacokinetic information remain important gaps.
BPC-157 is classified as a short synthetic peptide and is generally described as a pentadecapeptide.
Commonly reported sequence:
GEPPPGKPADDAGLV
Number of amino acids:
15
Commonly reported molecular mass:
Approximately 1,419 Da for the free peptide.
The precise chemical form matters when comparing research materials. For example, FDA's 2026 briefing materials distinguish BPC-157 free base from BPC-157 acetate as different active pharmaceutical ingredients. Researchers should therefore confirm whether a particular material is supplied as a free base, acetate, or another specified form rather than assuming that all BPC-157 products are chemically identical.
Research peptide selection should be based on documented identity, formulation, analytical characterization, handling requirements, and suitability for the intended experimental model.
BPC-157 has a substantial preclinical research history, which makes it a frequently discussed peptide in scientific literature. At the same time, its research status makes careful interpretation especially important. A 2025 review noted that BPC-157 has been studied in numerous preclinical models while also emphasizing that it has not received standard medical approval from the FDA and other major regulatory authorities.
For researchers, the value of a properly documented research material is not simply the compound name. It is the ability to identify what was actually used in an experiment and connect the material to appropriate analytical documentation.
Before purchasing BPC-157 Spray, researchers should verify:
BPC-157 Spray is intended for qualified research environments such as:
It is not intended for personal experimentation, self-administration, human consumption, veterinary use, diagnosis, treatment, or disease prevention.
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Cyclic peptides resist protease degradation and reach undruggable targets. Learn how peptide cyclization works and why stability improves. Explore the research.
How continuous flow, automation, enzymatic routes and AI are changing peptide synthesis technology, and what it means for research peptide purity and supply.
AI now designs peptides from scratch. How AlphaFold 3, RFdiffusion and protein language models reshaped peptide discovery in 2026 — research use only.
